Respiri Limited (ASX: RSH)
The recent spate of weather related asthma deaths brought home how vulnerable many people can be when faced with life threatening asthma related symptoms.
‘Thunderstorm asthma’ has increased awareness, however the rate of death caused by asthma has remained unchanged since 2003 despite all the advances in technology over past 14 years.
One ASX listed medtech company is looking to reverse these rates and make a real impact on the global asthma market via its suite of monitoring and management products.
This company has developed a world leading, comprehensive monitoring and management system that measures a patient’s wheezing.
Its consumer product could be considered as a “digital stethoscope”, connected to your smartphone via Bluetooth.
Offering a real time, continuous data stream for patient monitoring, this medical device stock is leveraged to the explosion in wearable health and fitness devices that is taking place.
There is a clear and growing addressable market for a company that could completely invigorate asthma monitoring products. This market is estimated to reach $47 billion this year, with over 330 million people globally suffering from asthma alone.
If it can have the impact it expects, it would potentially be looking to follow in the footsteps of other medtech companies that have attracted large valuations via attractive mergers and acquisitions deals.
The information on this page should not be the only trigger for your investment decision. Click on the links below for a more in-depth and informed examination of the company. We strongly recommend you seek professional financial advice whenever making financial investment decisions.
This company is making large leaps towards commercialisation and is directing its focus on securing partnership agreements to help launch a new generation of its continuous monitoring system in a large overseas market.
Currently valued by the market at a modest $16.4 million, if this company can fill the gap in the market for comprehensive and connected asthma monitoring systems, it would go a long way to reducing the impact on a crippling medical problem.